Liquid crystal nanogel capsule for treating colon cancer and preparation method thereof
A technology of gel capsules and colon cancer, applied in the direction of capsule delivery, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., which can solve problems such as inconvenient taking, need to use syringes, and low drug dosage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] A liquid crystal nanogel capsule for the treatment of colon cancer provided in this embodiment comprises the following components by weight: 4% anticancer active ingredient, 11% poloxamer, 50% natural phospholipid, fatty acid glyceride 27.5%, co-solvent 7.5%;
[0026] The camptothecin, doxorubicin and docetaxel respectively account for 75%, 12.5% and 12.5% of the anticancer active ingredients by weight.
[0027] A kind of preparation method of liquid crystal nanogel capsule for the treatment of colon cancer provided by the present embodiment comprises the following steps:
[0028] S1. Weigh poloxamer, natural phospholipids, fatty acid glycerides, co-solvent, stir at 40°C until completely dissolved, stirring at 400rpm, stirring for 14min to obtain an oily mixed solution;
[0029] S2. Weighing the anti-cancer active ingredient, adding it to the mixed solution obtained in step S1, and dispersing it by ultrasonic waves at a temperature of 70° C. for 10 minutes, with an...
Embodiment 2
[0032] This example is basically the same as Example 1, except that a liquid crystal nanogel capsule for the treatment of colon cancer provided in this example includes the following components in proportion by weight: anticancer active ingredient 6%, Poloxamer 14%, natural phospholipid 40%, fatty acid glyceride 30%, co-solvent 10%.
Embodiment 3
[0034] This example is basically the same as Example 1, except that the liquid crystal nanogel capsule for the treatment of colon cancer provided in this example includes the following components in proportion by weight: anticancer active ingredient 2%, Poloxamer 8%, natural phospholipid 60%, fatty acid glyceride 25%, co-solvent 5%.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com